The recently developed second-generation subcutaneous implantable cardioverter defibrillator (S-ICD) and the intermuscular two-incision implantation technique demonstrate potential favorable features that reduce inappropriate shocks and complications. However, data concerning large patient populations are lacking.
Padova, Italy). Baseline clinical characteristics, electrocardiographic abnormalities, indication for implantation, electrocardiogram (ECG) screening, and technical device characteristics were collected. The local ethics committee approved the study protocol and all patients provided written consent to be enrolled in the registry.
| S-ICD implantation technique, defibrillation testing, and device programming
Before implantation, all patients were screened for eligibility for S-ICD using the Boston Scientific manual ECG screening tool or the automated screening tool based on the surface ECG limb lead recording over the left and/or right parasternal regions to simulate the three S-ICD sensing vectors. To be eligible for S-ICD implantation, at least one ECG lead (I, II, or III) must satisfy the template (at any gain) in both erect and supine postures. All ECGs screening were reviewed by two experienced electrophysiologists blinded to patients, clinical presentation, and outcome. When there was disagreement, the ECG for that patient was adjudicated by a third independent observer. The procedure was performed in an electrophysiology laboratory under standard sterile conditions and general local anesthesia with conscious sedation or ultrasound-guided serratus anterior plane block. 9 Antibiotic prophylaxis was administered 1 hour before the procedure. The intermuscular twoincision technique was used for implantation, as previously reported in MIGLIORE ET AL. | 855 detail. 4 The intermuscular two-incision technique abandons the superior parasternal incision and consists of creating an intermuscular pocket (between the anterior surface of the serratus anterior muscle and the posterior surface of the latissimus dorsi muscle) for the pulse generator rather than a subcutaneous pocket using anatomical landmarks. The position of the lead and pulse generator relative to the heart silhouette is checked by fluoroscopy. An incision is made along the inframammary crease at the anterior edge of the latissimus dorsi. When the latissimus dorsi anterior edge is exposed, the pocket is created by blunt dissection between the superior surface of the serratus anterior muscle and the posterior surface of the latissimus dorsi muscle such that the pulse generator can be placed into the virtual anatomical space between the two muscles. When the serratus anterior is reached, it is important to recognize the change in the fiber pathway (horizontal vs vertical) to preserve the muscular fascia may and thereby minimize bleeding. A 2-cm horizontal incision at the level of the xiphoid process (xiphoid incision) is made in the direction of the pocket incision. The distal tip of the electrode insertion tool (EIT), which is used to create subcutaneous tunnels in which the electrode is placed, is inserted at the xiphoid incision and tunnelled laterally until the distal tip emerges at the device pocket. Conventional suture material is used to tie the anchoring hole of the electrode to the EIT. With the electrode attached, the EIT is pulled back through the tunnel to the xiphoid incision until the proximal sensing electrode emerges. A suture sleeve is placed over the electrode shaft 1 cm below the proximal sensing electrode. The preformed grooves are used to bind the suture sleeve to the electrode shaft using nonabsorbable suture material. The suture that connects the tip of the lead to the EIT is cut and removed. A peel-away sheath is placed over the shaft of the EIT, which is then tunnelled approximately 14 cm superior to the xiphoid incision and approximately 1 to 2 cm to the left or right of the sternal midline. The peel-away sheath is advanced over the EIT until it is fully inserted. The EIT is removed, and the peel-away sheath is left in its subcutaneous position. The electrode is inserted into the subcutaneous sheath until the suture sleeve reaches the opening of the sheath. The sheath is peeled away, leaving the electrode in place.
Correct placement of the tip of the lead at the required sternomanubrial location is confirmed digitally. The suture sleeve is secured to the fascia.
The proximal end of the lead is inserted into the connector port in the device header of the S-ICD and the screw set is tightened. Thus, the device is located in the intermuscular pocket and anchored to the fascia to prevent possible migration by using conventional nonabsorbable suture material. Particular attention is paid to ensure that the generator is placed posterior and inferior to the incision. Finally, the two muscles (serratus anterior and latissimus dorsi) are sutured using a conventional absorbable suture. Then, after device setup, the two incisions (xiphoid and pocket incisions) are closed using an intradermal suture.
After the procedure, defibrillation testing (DT) is performed after induction of ventricular fibrillation (VF) by 50 Hz stimulation. The DT is considered successful if the device detected and terminated VF using less than or equal to 65 J shock. In all patients, the device programming features included two tachyarrhythmia detection zones: (1) the shock-only zone, in which detection and therapy were based on rate only and (2) an additional "conditional zone," in which a morphology analysis algorithm was applied in addition to rate. Rate cutoffs were individualized for each patient based on clinical indications. The sensing vector (primary, secondary, or alternate) was automatically selected by the device at the time of implantation and optimized during supine and upright positions before. A chest X-ray was obtained the day after the procedure to confirm stable lead and generator positions. All S-ICD implantations were performed by experienced operators. The decision to perform post-implant DT and the type of anesthesia used were at the discretion of the implanting physician. Noncardiac oversensing was defined as any kind of oversensing due to noncardiac causes (eg, electromagnetic interference and myopotentials).
| Follow-Up

Episodes of inappropriate therapy were reviewed and verified with the
Boston Scientific Technical support team.
| Statistical analysis
Categorical variables are presented as actual numbers and frequencies. Continuous variables are expressed as the mean ± standard deviation (SD) for normally distributed variables or median (25th-75th percentile) for skewed variables, respectively. All analyses were performed using the SPSS statistic software. Data were analysed with SPSS, version 23 (IBM Corp., Armonk, NY).
| RESULTS
| Study population
The study population of this retrospective multicentre investiga- Table 1 . Twenty nine (29%) patients were implanted for secondary prevention. One (1%) patient was less than or equal to 18 years of age. At the time of ICD implantation, 78 (77%) patients were being treated with a β-blocker and 17 (17%) were receiving an antiarrhythmic agent. Left ventricular (LV) dysfunction (ejection fraction ≤ 50%) was present in 45 (44%) patients.
The reason for subcutaneous ICD placement was the presence of previous TV-ICD (patients underwent lead extraction for infection or lead failure) in 24 (24%) patients. In the remaining patients, the choice of implanting an S-ICD rather than a TV-ICD was at the discretion of the physician, which was based on clinical indications in accordance with current guidelines. 1 
| ECG screening
The primary sensing vector was the most compatible (55%), followed by the secondary vector (38%) and the alternate vector (7%). There were no cases with adjudication disagreement. 
| S-ICD implant characteristics
| S-ICD implantation technique: Safety and complications
The standard implantation technique of the S-ICD involved three incisions and placement of the pulse generator under the subcutaneous tissue. While S-ICD prevents drawbacks of the transvenous lead, an early experience with traditional implantation technique was associated with sizable rates of complications due to the large-volume pulse generator, including skin erosion, infection, and discomfort, especially, in thin individuals. 2, 4, [10] [11] [12] [13] For these reasons, new implantation techniques were explored to offer both operative and cosmetic advantages, including the intermuscular two-incision technique and submuscular technique. [5] [6] [7] [8] The two-incision technique 8 has been developed first to 4, 8, 14 The most commonly adopted technique is the intermuscular two-incision technique. This approach can offer better cosmetic results due to the deeper position of the pulse, and seems to prevent pocket complications and infections. 6, 7 Furthermore, anatomical landmarks ensure the right position of the pulse generator in obese patients. 6, 7 Moreover, using the intermuscular pocket approach, a more posterior placement (dorsally) of the device with less adipose tissue between the pulse generator and the chest ( ate therapies. 6 The present multicentre prospective study, which has the largest study population and a longer, extended follow-up period, confirms these previous results.
In our study, intraoperative-induced arrhythmia conversion success at less than or equal to 65 J without pulse generator adjustments was considerably higher than that reported by previous studies (98.75% vs 90.2-91.2). 2 The dorsal placement of the pulse generator captures more ventricular mass and avoids the subgenerator fat, which results in increased shock impedance and decreases the effective current traversing the heart. [18] [19] [20] Although questionable, increased shock impedance is reported to be associated with failed conversion testing, and, therefore, one might wonder if impedance can be used as a predictor for shock efficacy. 18 Currently, as a rule of thumb, a high impedance more than or equal to 100 Ω is generally considered a risk for lower shock efficacy, 19 as insulation of the F I G U R E 2 Subcutaneous implantable cardioverter defibrillator stored electrogram of inappropriate shock due to supraventricular tachycardia in a patient with dilated cardiomyopathy [Color figure can be viewed at wileyonlinelibrary.com] S-ICD system in adipose tissue increases resistance and creates a less efficient energy gradient. In our study, the mean value of impedance was 66 ± 12 Ω and no patients reported high impedance.
Recent studies showed that there is a learning curve involved in implanting and programming the S-ICD. 20 Thus, we recommend that physicians first become confident with the anatomical landmarks and technical issues of the traditional implantation technique. thies and channelopathies) that might benefit more from S-ICD will also be those characteristics that lead to markedly abnormal and frequently dynamic ECGs and thus, lead to greater exposure to inappropriate shocks. 21 
| Need of ATP and pacing
The European Heart Rhythm Association prospective snapshot survey showed that among factors favouring the use of a transvenous device, despite being a significant economic factor (18.5%), the three most important reasons included: the option of ATP (43.2%), and the current or expected need for CRT (40%) or permanent pacing (39.6%).
Interestingly, the patient preference (2.9%), size of the device (1.8%), and aesthetical reasons (0.4%) all had negligible impact. 24 This study demonstrated that the potential need of ATP seemed to guide the clinician's decision-making. In fact, only a few patients (1-2%/annum) will develop an indication for pacing therapy. 23 In the long-term follow- F I G U R E 5 Chest X-ray anteroposterior view (A), and lateral view (B) after S-ICD implantation using the intermuscular two-incision technique. Note the virtual space between the pulse generator and the posterior placement (dorsal) of the device that may provide an improved vector toward the shocking coil capturing more left ventricular mass compared with the conventional subcutaneous approach had the device removed for conceived need for ATP. In the PAS study, combination of the cohorts with recurrent MVT and exchange for ATP led to an annualized rate of 0.9% patients who might have benefitted from ATP. 3 The MADIT-RIT study showed that the programming of ICD therapies for tachyarrhythmias of 200 bpm or higher, or with a prolonged delay in therapy at 170 bpm or higher compared with conventional programming, was associated with reductions in inappropriate therapy and all-cause mortality during long-term follow-up. 25 These findings bring into question the usefulness of ATP therapy and strongly argue that, in addition to patients with previous recurrent MVT, the lack of ATP in the S-ICD should not be a factor in selecting appropriate patients for this technology.
| Limitations
A potential limitation of the intermuscular two-incision technique could be a possible greater complexity for battery replacement. However, we believe that both the long battery life of the current EMBLEM S-ICD system as well as the reduction of acute and late complications may overcome this limitation. Another limitation is that our study sample mostly comprised young patients with ion channel diseases or cardiomyopathies with preserved or mildly reduced LV ejection fractions, and thus is not representative of the overall population receiving an ICD.
Moreover, our study is biased because of its retrospective nature and because of the participation of selected centers. Although we reported a systematic implantation technique, the decision to perform postimplantation DT was left to physician discretions and center preference. However, DT was performed successfully in the majority of patients. Of note, two patients who did not undergo DT experienced appropriate and successful shocks for VA during follow-up. Moreover, all procedures were performed by experienced operators, and therefore, our results may not be widely applicable in less experienced centers. Finally, even if our data were collected from a multicentre registry with the largest study population observed to date, with the most recent advances of S-ICD (EMBLEM S-ICD and the intermuscular two-incision technique), largerscale, randomized prospective studies should be conducted in the future to verify our findings and to compare the clinical success and safety of different techniques.
| CONCLUSIONS
According to our multicentre study, second-generation S-ICD implanted with the intermuscular two-incision technique is a safe combination and appears to be associated with a low risk of complications, such as inappropriate shocks. ORCID Federico Migliore http://orcid.org/0000-0001-8574-9421
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